We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+10.34%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$23.5B
AUM Growth
+$2.05B
Cap. Flow
-$1.67M
Cap. Flow %
-0.01%
Top 10 Hldgs %
21.02%
Holding
3,355
New
222
Increased
1,262
Reduced
1,627
Closed
171

Sector Composition

Rank Sector Weight
1 Technology 10.74%
2 Financials 4.97%
3 Consumer Discretionary 4.15%
4 Healthcare 3.65%
5 Industrials 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TACK icon
3301
Fairlead Tactical Sector ETF
TACK
$305M
-10,732
Closed -$243K
TBF icon
3302
ProShares Short 20+ Year Treasury ETF
TBF
$106M
-71,968
Closed -$1.81M
TDC icon
3303
Teradata
TDC
$2.49B
-4,510
Closed -$203K
TRVG
3304
trivago
TRVG
$368M
-19,880
Closed -$104K
UNL icon
3305
United States 12 Month Natural Gas Fund
UNL
$13.5M
-13,997
Closed -$152K
USAU icon
3306
US Gold Corp
USAU
$252M
-11,410
Closed -$35K
USEA icon
3307
United Maritime
USEA
$25.6M
-34,922
Closed -$84K
UTEN icon
3308
US Treasury 10 Year Note ETF
UTEN
$288M
-12,491
Closed -$535K
VEGI icon
3309
iShares MSCI Agriculture Producers ETF
VEGI
$148M
-7,387
Closed -$281K
VIDI icon
3310
Vident International Equity Strategy
VIDI
$449M
-10,971
Closed -$248K
VUSE icon
3311
Vident US Equity Strategy ETF
VUSE
$690M
-12,105
Closed -$567K
WCC
3312
WESCO International
WCC
$17.8B
-1,429
Closed -$206K
WLY icon
3313
John Wiley & Sons Class A
WLY
$2.53B
-10,090
Closed -$375K
XPL icon
3314
Solitario Resources
XPL
$73.6M
-99,761
Closed -$54K
ZYXI
3315
DELISTED
Zynex
ZYXI
-22,188
Closed -$178K
HEAL
3316
Global X Funds Global X HealthTech ETF
HEAL
$30.7M
-4,455
Closed -$123K
BECN
3317
DELISTED
Beacon Roofing Supply, Inc.
BECN
-4,209
Closed -$325K
GETR
3318
DELISTED
Getaround, Inc.
GETR
-11,000
Closed -$4K
DMTK
3319
DELISTED
DermTech, Inc. Common Stock
DMTK
-10,241
Closed -$15K
TTOO
3320
DELISTED
T2 Biosystems, Inc
TTOO
-104
Closed -$2K
AJXA
3321
DELISTED
Great Ajax Corp.7.25% Convertible Senior Notes due 2024
AJXA
-14,625
Closed -$353K
PARAP
3322
DELISTED
Paramount Global 5.75% Series A Mandatory Convertible Preferred Stock
PARAP
-24,257
Closed -$431K
IMGN
3323
DELISTED
Immunogen Inc
IMGN
-21,362
Closed -$339K
FTCH
3324
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
-24,697
Closed -$52K
BSMN
3325
DELISTED
Invesco BulletShares 2023 Municipal Bond ETF
BSMN
-60,766
Closed -$1.52M

Similar funds

Cambridge Investment Research Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Cambridge Investment Research Advisors held 3,355 positions worth $23.5B, up 9.6% from $21.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cambridge Investment Research Advisors's Q4 2023 filing shows 222 new, 1,262 increased, 1,627 reduced and 171 closed positions. Its largest new stake was Innovator Equity Managed Floor ETF: 254,744 shares worth $6.96M. The largest sale was iShares 0-1 Year Treasury Bond ETF, an estimated $62.7M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q4 2023 buy was Innovator Equity Managed Floor ETF: 254,744 shares worth $6.96M.
  • Cambridge Investment Research Advisors added most to Invesco QQQ Trust in Q4 2023, an estimated $73.8M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $62.7M.
  • Cambridge Investment Research Advisors fully exited Invesco BulletShares 2023 Corporate Bond ETF in Q4 2023, selling an estimated $15M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $23.5B portfolio in Q4 2023.
  • Cambridge Investment Research Advisors opened 222 new positions and closed 171 in Q4 2023.
  • Cambridge Investment Research Advisors's portfolio value rose 9.6% quarter-over-quarter to $23.5B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.